BRCA Founder OutReach (BFOR) Study

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: BRCA2 Mutation; BRCA1 Mutation

Treatments: Other: BFOR Digital Health solution/Web Portal

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03351803

17-568

Details and patient eligibility

About

The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.

Enrollment: 5,412 patients

Sex: All

Ages: 25+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Self-reported age ≥ 25
• Self identify as having at least one of their four grandparents as Ashkenazi Jewish
• Has medical insurance
• Able to understand and read the English-language
• Zip code falls within the catchment areas of the phase of the study (e.g. New York City, Boston, Philadelphia, Los Angeles) accessible to a BFOR designated provider

Exclusion criteria

• Under age 25
• No Ashkenazi Jewish ancestry
• Does not have insurance
• Has previously had medical BRCA testing ordered by a health care provider

Trial design

5,412 participants in 1 patient group

Participants with Ashkenazi ancestry

Treatment:

Other: BFOR Digital Health solution/Web Portal